Merck (MRK) tops Q3 expectations on sustained growth in oncology and vaccine segments
October 26, 2023 9:26 AM
Merck (NYSE: MRK) reported earnings before the open Thursday, topping both profit and revenue consensus expectations. The pharmaceutical company reported ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
